Table 2. . Distribution of phthalate metabolite concentrations averaged across pregnancy.
| Phthalate metabolite | Pregnancy average (n = 265) | |||
|---|---|---|---|---|
| Median | IQR | Minimum | Maximum | |
| MEP | 214.2 | (90.7–444.7) | 7.2 | 6607.7 |
| MBP | 24.4 | (14.2–45.3) | 3.2 | 228.6 |
| MiBP | 2.7 | (1.6–5.3) | 0.1 | 192.0 |
| MEHP | 3.9 | (2.2–7.0) | 0.1 | 101.6 |
| MEHHP | 16.1 | (9.5–29.2) | 1.4 | 478.6 |
| MEOHP | 12.1 | (7.0–20.7) | 0.9 | 353.4 |
| MECPP | 26.7 | (17.7–45.3) | 5.3 | 665.2 |
| ΣDEHP | 60.9 | (37.1–98.5) | 8.0 | 1524.5 |
| MBzP | 8.2 | (4.7–13.8) | 0.5 | 97.4 |
| MCPP | 2.0 | (1.3–2.9) | 0.1 | 28.3 |
| MCOP | 3.4 | (2.1–4.7) | 0.5 | 82.7 |
| MCNP | 1.9 | (1.3–2.6) | 0.3 | 17.1 |
All units are in μg/g creatinine.
DEHP: Di-2-ethylhexyl phthalate; IQR: Interquartile range; MBP: Mono-n-butyl phthalate; MBzP: Monobenzyl phthalate; MCNP: Monocarboxynonyl phthalate; MCOP: Monocarboxyoctyl phthalate; MCPP: Mono(3-carboxypropyl) phthalate; MECPP: Mono(2-ethyl-5-carboxypentyl) phthalate; MEHHP: Mono(2-ethyl-5-hydroxyhexyl) phthalate; MEHP: Mono(2-ethylhexyl) phthalate; MEOHP: Mono(2-ethyl-5-oxohexyl) phthalate; MEP: Monoethyl phthalate; MiBP: Mono-isobutyl phthalate.